Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-03 · accession 0001622058-25-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-03 | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $590.69 | -668 | 646.2K | -0.1% | -$394.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | S | D | 668 | $590.69 | 646,184 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $591.61. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |